Barclays Issues Pessimistic Forecast for UnitedHealth Group (NYSE:UNH) Stock Price

UnitedHealth Group (NYSE:UNH) had its price objective dropped by investment analysts at Barclays from $441.00 to $440.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has an “overweight” rating on the healthcare conglomerate’s stock. Barclays‘s price target points to a potential upside of 13.15% from the stock’s current price.

A number of other research analysts also recently weighed in on the company. HSBC upped their target price on UnitedHealth Group from $300.00 to $380.00 and gave the stock a “hold” rating in a report on Monday, July 6th. Wall Street Zen upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. TD Cowen dropped their price target on UnitedHealth Group from $430.00 to $402.00 and set a “hold” rating on the stock in a research report on Friday. Weiss Ratings raised UnitedHealth Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, October 8th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on UnitedHealth Group from $370.00 to $467.00 and gave the stock a “hold” rating in a report on Friday, July 17th. Twenty equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $461.66.

UnitedHealth Group Trading Up 2.9%

UNH stock traded up $11.10 on Wednesday, reaching $388.86. The company’s stock had a trading volume of 2,003,904 shares, compared to its average volume of 7,342,901. The firm has a market cap of $349.03 billion, a PE ratio of 25.06, a PEG ratio of 1.42 and a beta of 0.60. The business has a fifty day simple moving average of $387.44 and a two-hundred day simple moving average of $382.57. UnitedHealth Group has a 12-month low of $255.96 and a 12-month high of $461.62. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.78.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business had revenue of $112.70 billion for the quarter, compared to the consensus estimate of $111.31 billion. During the same period in the previous year, the firm earned $2.59 EPS. The company’s quarterly revenue was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, research analysts forecast that UnitedHealth Group will post 19.85 EPS for the current year.

Insider Activity

In related news, CEO Patrick Conway sold 1,169 shares of the company’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. The trade was a 7.09% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.19% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Wellington Altus USA Inc. increased its holdings in shares of UnitedHealth Group by 97.1% in the second quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 33 shares during the period. Security National Bank of SO Dak acquired a new stake in shares of UnitedHealth Group during the second quarter worth about $29,000. Aberdeen Wealth Management LLC purchased a new stake in UnitedHealth Group in the second quarter valued at approximately $31,000. Nalls Sherbakoff Group LLC acquired a new position in UnitedHealth Group in the 4th quarter worth approximately $27,000. Finally, Lifetime Wealth Management P.C. acquired a new position in UnitedHealth Group in the 4th quarter worth approximately $29,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Strong Q3 beat and raised outlook: Adjusted earnings of $4.69 per share exceeded the roughly $4.14 consensus, while revenue of $112.7 billion also topped estimates. Operating profit increased 52%, supported by lower medical costs and better execution. UnitedHealth raised its 2026 adjusted EPS outlook to at least $20.50, above the approximately $19.86 analyst consensus. UnitedHealth Group tops estimates, hikes profit outlook as insurer manages high medical costs
• Positive Sentiment: Improving margins and efficiency: The medical care ratio improved to 88.4%, while management highlighted artificial-intelligence initiatives that reduce administrative work and clinical review times. Management also suggested Wall Street may be underestimating 2027 earnings potential and outlined longer-term earnings growth of 13% to 16%. UnitedHealth Q3 2026 Earnings Call Transcript
• Neutral Sentiment: Analyst views are mixed: Mizuho named UNH a top pick, but TD Cowen remained cautious. Robert W. Baird lowered its price target to $427 from $453 and maintained a neutral rating, signaling upside but less confidence in the recovery. UnitedHealth Stock Forecast: TD Cowen Stays Cautious Even as Mizuho Names UNH a Top Pick
• Negative Sentiment: Growth and business-mix concerns remain: Quarterly revenue declined slightly year over year, Optum Health revenue reportedly slipped, and UnitedHealth’s Medicare business exit is creating uncertainty around future membership and profitability. Investors also remain focused on Medicaid margins, which management expects to improve after 2026. UnitedHealth Group Drops 5.4% as Medicare Exit Clouds Q3 Beat

About UnitedHealth Group

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.